Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma (Q34567445)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma (English)
1 reference
Christos Emmanouilides
1 reference
Thomas E Witzig
1 reference
Leo I Gordon
1 reference
Katie Vo
1 reference
Gregory A Wiseman
1 reference
Ian W Flinn
1 reference
Mohamed Darif
1 reference
Russell J Schilder
1 reference
Arturo Molina
1 reference
1 April 2006
1 reference
1 reference
47
1 reference
4
1 reference
629-636
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference